University of Chicago, Chicago, IL, USA Daniel W. Golden Corresponding author Correspondence to Nicholas G. Zaorsky . Editor information Editors and Affiliations Department of Radiation Oncology, Mayo Clinic, Jacksonville, FL, USA Daniel M. Trifiletti Department of Radiation Oncology, Penn State Can...
Med. Markus Alber, University Hospital of Tübingen, Germany Professor David Azria, PhD, Institute of Cancer Research of Montpellier, France Professor Dr. Med. Peter Bartenstein, Ludwig Maximilian University of Munich, Germany Professor Andy Beavis, PhD, Queens Centre for Oncology & Haematology, UK...
College of Medicine, University of Illinois at Chicago, Chicago, IL, USA.Steve E.BraunsteinDepartment of Radiation Oncology, University of California, San Francisco, CA, USA.Emma C.FieldsDepartment of Radiation Oncology, Virginia Commonwealth University, Richmond, VA, USA.Erin F.Gillespie...
Radiation Oncology volume 7, Article number: 156 (2012) Cite this article 5336 Accesses 15 Citations Metrics details Abstract Background Unresectable pancreatic cancer (UPC) has low survival. With improving staging techniques and systemic therapy, local control in patients without metastatic disease may...
"Our findings provide initial robust evidence that testing for circulating tumor cells may be an important tool in helping to guide recommendations for radiation therapy," said Chelain Goodman, a resident in radiation oncology at NU Medicine and also first author of the study. ...
CHICAGO, Dec. 26 (Xinhua) -- Cancer patients who receive high-tech proton therapy experience similar cure rates and fewer serious side effects compared with those who undergo traditional X-ray radiation therapy, according to a study published Thursday in the medical journal JAMA Oncology. ...
Department of Radiation and Cellular Oncology, The University of Chicago, Chicago, IL, USA Liam F. Spurr, Carlos A. Martinez, Robyn Hseu, Stanley I. Gutiontov, William T. Turchan, Connor M. Lynch, Kelli B. Pointer, Ralph R. Weichselbaum, Steven J. Chmura & Sean P. Pitroda ...
By the completion of the residency, the physics resident is expected to be able to perform all radiation oncology physics functions. FinancialThe medical physics residency position at CARTI will be a full-time salaried new employee. As such, this position will qualify for the same benefits as ...
Meeting Presentation: The trial was selected for Oral Presentation at American Society of Clinical Oncology (ASCO) Annual Meeting (abstract ID: 6000): June 3, 2022; Chicago, Illinois. Data Sharing Statement: See Supplement 3. Additional Contributions: We thank the patients who participated in this...
Neoadjuvant vindesine, etoposide, and cisplatin for locally advanced non-small cell lung cancer. Final report of a phase 2 study : Vokes EE, Bitran JD, Hoffman PC, Ferguson MK, Weichselbaum RR, Golomb HM. Joint Section of Hematology/Oncology, Department of Radiation Oncology, University of ...